GlycoEra AG appoints Tanmoy Ganguly as Chief Scientific Officer
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
Thermo Scientific Direct Mass Technology mode augments Thermo Scientific Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers with charge detection capabilities
Group 4 Medulloblastoma is a rare disease that mostly affects pediatric patients, in which aberrant SRC signaling was identified as a hallmark of the disease
Company hires life science veteran Jessica Cao to join management team
Bayer now present in four of the largest biotechnology hubs in the United States
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Subscribe To Our Newsletter & Stay Updated